Hi, USAFA!Also, does anyone know if Baxter is in the acquisition mode?If you haven't heard already, Baxter announced today that it was acquiring vaccine developer North AmericanVaccine Inc. (AMEX: NVX) in a deal valued at $390 million. Baxter will pay $6.97 in Baxter stock and $0.03 in cash for each of North American Vaccine's 37 million outstanding shares(diluted).For more details, click "News" above (to the right of the folder name).Fool on!Vince
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat